MT1G and hepatocellular carcinoma: At present, it is considered that enhancing the ferroptosis sensitivity of HCC is an effective way to solve sorafenib resistance, such as upregulation of MT-1G or antagonism of NRF2 (Sun et al., 2016a; Sun et al., 2016b).